189 related articles for article (PubMed ID: 17426092)
1. Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome.
Goodarzi MO; Antoine HJ; Azziz R
J Clin Endocrinol Metab; 2007 Jul; 92(7):2659-64. PubMed ID: 17426092
[TBL] [Abstract][Full Text] [Related]
2. Variants in SULT2A1 affect the DHEA sulphate to DHEA ratio in patients with polycystic ovary syndrome but not the hyperandrogenic phenotype.
Louwers YV; de Jong FH; van Herwaarden NA; Stolk L; Fauser BC; Uitterlinden AG; Laven JS
J Clin Endocrinol Metab; 2013 Sep; 98(9):3848-55. PubMed ID: 23861462
[TBL] [Abstract][Full Text] [Related]
3. Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women.
Goodarzi MO; Shah NA; Antoine HJ; Pall M; Guo X; Azziz R
J Clin Endocrinol Metab; 2006 Oct; 91(10):4085-91. PubMed ID: 16849416
[TBL] [Abstract][Full Text] [Related]
4. Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome.
Goodarzi MO; Xu N; Azziz R
J Clin Endocrinol Metab; 2008 Jul; 93(7):2909-12. PubMed ID: 18445661
[TBL] [Abstract][Full Text] [Related]
5. DHEA, DHEAS and PCOS.
Goodarzi MO; Carmina E; Azziz R
J Steroid Biochem Mol Biol; 2015 Jan; 145():213-25. PubMed ID: 25008465
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome.
Antoine HJ; Pall M; Trader BC; Chen YD; Azziz R; Goodarzi MO
Fertil Steril; 2007 Apr; 87(4):862-9. PubMed ID: 17141766
[TBL] [Abstract][Full Text] [Related]
7. A SULT2A1 genetic variant identified by GWAS as associated with low serum DHEAS does not impact on the actual DHEA/DHEAS ratio.
Haring R; Wallaschofski H; Teumer A; Kroemer H; Taylor AE; Shackleton CH; Nauck M; Völker U; Homuth G; Arlt W
J Mol Endocrinol; 2013 Feb; 50(1):73-7. PubMed ID: 23132913
[TBL] [Abstract][Full Text] [Related]
8. Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.
Lerchbaum E; Schwetz V; Giuliani A; Pieber TR; Obermayer-Pietsch B
Fertil Steril; 2012 Nov; 98(5):1318-25.e1. PubMed ID: 22835450
[TBL] [Abstract][Full Text] [Related]
9. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
[TBL] [Abstract][Full Text] [Related]
10. Nonreplication of the type 5 17beta-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome.
Goodarzi MO; Jones MR; Antoine HJ; Pall M; Chen YD; Azziz R
J Clin Endocrinol Metab; 2008 Jan; 93(1):300-3. PubMed ID: 17940109
[TBL] [Abstract][Full Text] [Related]
11. Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters.
Yildiz BO; Goodarzi MO; Guo X; Rotter JI; Azziz R
Fertil Steril; 2006 Dec; 86(6):1688-93. PubMed ID: 17074350
[TBL] [Abstract][Full Text] [Related]
12. Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome.
Xu N; Taylor KD; Azziz R; Goodarzi MO
Fertil Steril; 2010 Jun; 94(1):255-60.e1-2. PubMed ID: 19327767
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess.
Witchel SF; Kahsar-Miller M; Aston CE; White C; Azziz R
Fertil Steril; 2005 Feb; 83(2):371-5. PubMed ID: 15705377
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of STS gene and SULT2A1 gene and neurosteroid levels in Han Chinese boys with attention-deficit/hyperactivity disorder: an exploratory investigation.
Wang LJ; Chan WC; Chou MC; Chou WJ; Lee MJ; Lee SY; Lin PY; Yang YH; Yen CF
Sci Rep; 2017 Apr; 7():45595. PubMed ID: 28367959
[TBL] [Abstract][Full Text] [Related]
15. Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome.
Yildiz BO; Woods KS; Stanczyk F; Bartolucci A; Azziz R
J Clin Endocrinol Metab; 2004 Nov; 89(11):5558-62. PubMed ID: 15531511
[TBL] [Abstract][Full Text] [Related]
16. Steroid sulfatase (STS) expression in the human temporal lobe: enzyme activity, mRNA expression and immunohistochemistry study.
Steckelbroeck S; Nassen A; Ugele B; Ludwig M; Watzka M; Reissinger A; Clusmann H; Lütjohann D; Siekmann L; Klingmüller D; Hans VH
J Neurochem; 2004 Apr; 89(2):403-17. PubMed ID: 15056284
[TBL] [Abstract][Full Text] [Related]
17. Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene.
Jones MR; Mathur R; Cui J; Guo X; Azziz R; Goodarzi MO
J Clin Endocrinol Metab; 2009 Dec; 94(12):5034-8. PubMed ID: 19837928
[TBL] [Abstract][Full Text] [Related]
18. Steroid sulfatase gene variation and DHEA responsiveness to resistance exercise in MERET.
Riechman SE; Fabian TJ; Kroboth PD; Ferrell RE
Physiol Genomics; 2004 May; 17(3):300-6. PubMed ID: 15152080
[TBL] [Abstract][Full Text] [Related]
19. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
20. First evidence of genetic association between AKT2 and polycystic ovary syndrome.
Goodarzi MO; Jones MR; Chen YD; Azziz R
Diabetes Care; 2008 Dec; 31(12):2284-7. PubMed ID: 18768676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
